Corporate VC

Join Me Monday Night to Talk Digital Healthcare

As many of you know, I help lead the Tech Council at Boston College.  It is a strong group with active chapters in NY, SF and Boston.

Monday the 12th we have a great event in Boston. Healthcare is becoming the foundation of the Boston economy and it is being transformed as technologists tackle the problems of improving care and improving the economics of care.

Come to District Hall, the innovation center of The Seaport, to talk with 100 local tech and healthcare investors & execs about how to build HCIT businesses in this turbulent regulatory and reimbursement environment.  We’ll get started with a strong panel featuring PE leader Matt Carroll from Westview Capital & the Founders of Imprivata, Cyft & Definitive Healthcare.

Open to any and all, even folks that went to Holy Cross.  Details here:  http://bit.ly/2sGLssD  Hope you can join me.

 

Building a Successful Corporate Venture Arm

Companies are creating Corporate Venture Capital (“CVC) funds at a healthy pace as shown by CB Insights in the chart below.  I suspect a few Fortune 1000 Boards and CEOs are wondering if they should have a fund or if their existing fund is set up correctly.  Below is a framework for building a successful team making strategic minority investments.

CVC Growth

Start with a clear review of purpose.  There are several valid reasons CVC units are formed, but you should be disciplined about the mission of your CVC unit.  Some CVC units, like that at Salesforce, are built to create or support an ecosystem around a company platform.  Units can be focused on “crowdsourcing” R&D with early stage investments in companies conducting core research to prove product viability.  This strategy is very common in the life sciences industry.  A CVC can focus on monetizing internal R&D via spin-outs, as practiced by many research hospitals.  A CVC team can also be built to seed and diligence a future M&A pipeline as Cisco has done successfully for decades.  In some cases, CVC is just a higher ROI use of cash than internal projects or dividends. Whatever the reason, be disciplined about the purpose and avoid building a CVC just because a competitor has one.

Next, be brutally honest in assessing what value you can, and are willing, to deliver to a portfolio company.  Cash is a commodity.  You will be selling a strategic value such as distribution, assistance in getting to international markets, expertise to scale manufacturing or build a supply chain.  This is your value prop and your CVC effort should be organized around delivering it and targeting companies that value it.

Once purpose and value are established, think about scope.  Decide if a dedicated fund is the right answer for your company.  There are hybrid models like Touchdown Ventures with an outsourced team.  There are also narrow funds close to your industry where you might become an LP.  If there isn’t one in your industry, consider starting one with institutional or corporate partners.  The dedicated fund offers the most impact and control, but it is not the only option.

If you are building a dedicated team, the next issues to consider are sponsorship, structure and staffing.  By sponsorship, I mean an internal champion.  Successful CVC programs have an internally visible, very senior leader.  The leader pushes a large organization to deliver on its value prop to the portfolio.  Comcast Ventures is a great example, where company co-founder Julian Brodsky as a senior sponsor could cause the organization to support the portfolio.

The structure reference is primarily to legal structure, but also includes financial commitments and external messaging.  Your CVC is most likely to be a syndicate partner, so your structure and messaging need to resonate with your fellow investors.  These investors will be most comfortable partnering with something they recognize – a dedicated legal entity with a defined capital commitment.  Set up a dedicated entity and get the board to approve a commitment amount that you can announce to the market.  The other argument for a separate entity is that it provides some comfort to portfolio companies who can be fearful of sharing an ownership interest in their IP directly with a large, well-funded participant in their market.

QuoteWhen staffing the CVC unit, you need to blend external expertise and credibility with internal relationships and credibility.  Sourcing, structuring and supporting a portfolio of start-ups is likely not an internal capability.  You should hire externally for the leaders and externally facing executives of the CVC effort.  Equally, a group of new hires will struggle to deliver on your value proposition as the new hires lack the internal knowledge and relationships to make the organization responsive to the portfolio.  The team needs the capability to source externally and deliver internally, so select your people accordingly.  I like what GV, formerly Google Ventures, did in this regard.  They had a broad bench of execs that supported the CVC, many on an as-needed basis tuned to their expertise.  Making the CVC a portion of an executive’s role is a great way to organize functional support in areas like finance and legal.  A dedicated person from the functional unit to support the CVC creates the benefit of a future experience curve without the overhead of full-time resources.  Forward thinking CVCs also have a dedicated HR exec, not for HR within the CVC, but as a resource to help the portfolio.

To attract and retain a staff, you must get the compensation plan right.  Dozens of flavors exist, but the effective ones all have some form of “carry”, an explicit connection between investment success and team pay.  People with the experience to help build companies have many employment options.  Creating a competitive pay plan requires offering upside beyond base salaries. You want the team’s upside tied to results delivered to shareholders, not a bonus for simply making an investment.  The upside incentive should also be shared with the internal resources that were key in delivering your value prop to the portfolio.  The details of comp plans are a separate long topic, but prepare to connect it to results and find a way to be tax efficient.  Your HR department is going to need to think differently for this business unit.

With all the preparation in place, the hard part begins.  Below are a few tactics that will make your effort successful once you are in the market:

  • Deliver your value prop – The best marketing to prospective portfolio companies is over-delivering for your current portfolio. Be aggressive about it and benchmark your progress with frequent feedback from your CEOs.
  • Target a few co-investors – Co-investor relationships are built on a trust that can only be created by working together. Accelerate that process by targeting a handful of core co-investors.  Prove your value to these folks, they will become your reference to the rest of the market.
  • Embrace speed – Nearly all CVCs make decisions too slowly. They wait for too many levels of approval or a scarce time slot on the CEO’s calendar. Streamline your approval processes and invest in diligence resources to match the market cycle time for syndicate formation and term sheet approval.
  • Learn to partner – Big companies can derail small companies when they insist on warping the portfolio company product roadmap and go-to-market plans toward the agenda of the big company.  If you need that degree of influence, buy the business rather than invest.  Learn to be a minority investor and be mindful that the portfolio companies are not your business units.

I hope the above is helpful.  My final advice to those thinking about building or revamping a CVC: Never put a lawyer from your M&A team in charge of the effort.  No idea why this gets done, but it does and it’s a direct path to a large write-down.

 


 

Tech Market Update – Gartner CEO Summit

Include PE Buyers in your M&A Process Curious Incident of the Disappearing IPO

Our friends @Gartner_Inc invited me to speak yesterday at their Annual CEO Summit. I met some interesting people. Two of the speaking Analysts are leading projects around B2B buying processes and behaviors. Gartner has done some interesting analysis here, including creating a framework of Enterprise Buying Personalities. Worth checking out if you are a B2B marketer.

My segment was an update on the Tech Capital Markets generally, and the fundraising environment in particular. The slides from the discussion can be found here.

While reviewing our market data in preparation for the talk a couple of points jumped out at me:

  • The IPO market overall, but particularly in tech, is really off this year. Take a look at the data beginning on Page 12 of the deck. Dan Primack forecasted yesterday in his daily post that we are headed for the lowest number of VC-backed IPOs since the 2009 recession.
  • Public investors like Fidelity may not be crossing over into the private markets in search of outsized returns. They may be doing it as the lack of tech IPOs is offering them fewer alternatives to add new tech names to portfolios.
  • Take a look on Page 22 to see what investors in the latest round for @Snapchat could have bought instead….

Raising Growth Capital? Use a Banker.

Smart companies are adapting as the growth capital market has evolved

Disruptive tech companies are good at product and business model innovation, but they can be just as guilty as a Cleveland steel mill of “way we’ve always done it” operating behavior.  One behavior that puzzles me is the CEO or Board that has not adapted its funding plans to the shift in the private capital markets.  25 years ago venture capital and growth equity may have been the same market, best accessed with the same process, but today they are different markets that require different thinking and different processes.

(more…)

What Does HIMSS15 Tell Us About Venture Investment in Healthcare IT?

Over 20,000 people will gather next week in Chicago for this year’s HIMSS conference.  This nexus of the digital health world is a must-attend event for HCIT vendors.  The attendee list allows us to get a snapshot of how the venture industry is impacting healthcare technology.

VCs should be attracted to improving healthcare delivery.  Big returns come from solving big problems.  The cost, availability and quality of healthcare are big problems.  The Kaiser Foundation reports US healthcare costs have expanded from 7.2% of GDP in 1970 to 20% of GDP in 2015.  Venture returns are created when large existing systems undergo change.  US healthcare is a trillion dollar system with core drivers in place for change.  Many hospitals are operating with tech infrastructure that is a generation behind and implementation of the ACA is disrupting the system in ways both intentional and unexpected.

(more…)

2015 Tech Growth Equity Outlook

What is in store after a transformational year in 2014?

Predictions for the tech growth equity market in 20152014 was a banner year for tech companies raising growth equity in the private market. Investors committed $74B to drive growth and provide liquidity. At least 21 new companies joined the “Unicorn” club with valuations in excess of $1,000,000,000.   Uber raised capital late in the year at a $41B value, a market cap that would rank it 32nd among all NASDAQ listed companies were Uber public. The private market universe expanded with mutual funds, hedge funds and corporate investors increasing their private portfolios. Marc Andreessen and Bill Gurley began to raise alarm bells about the market and company burn rates overheating.

So how does a company considering raising funds plan for 2015?  Read our full report here.

(more…)

Up Rounds & Simpler Terms – Q3 Tale of the Tape

Investors are Pricing Rounds Up, but Fearing the Bubble

Analytics are out on the private financing market during Q3.  We should all appreciate that Wilson Sonsini and Cooley each make the effort to aggregate and publish term sheet analytics.  The law firms can only report on transactions where they advise, but the collective data are by far the most detailed view into trends in term sheet structure.

The big takeaway for CEOs thinking of funding is that capital remains available – 80+% of all financing rounds were up rounds in Q3.  WSGR reports it is the highest level of up rounds since they began tracking data.  The WSGR graph below shows the recent quarterly trend:

Screen Shot 2014-11-07 at 3.07.40 PM

It is unlikely that 80+% of portfolio companies are making their budget numbers.   Therefore, the wealth of up rounds suggests investors are giving companies the benefit of the doubt and placing credence in future growth plans.

(more…)

What Market Slowdown?

Busy week in our market.  Private tech growth investors of all flavors – corporate, financial and crossover – deployed $2.5 billion since last Friday.

Week of Oct 20

Interesting to note how active the corporate investors were.  Strategic priorities such as mobile and virtual reality were backed by significant balance sheet commitments.  The snapshot of this past week also reinforces how broad and how global the market has become.

 

Private Tech Finance Ahead of 2013 & Bigger than IPO Market

Market healthy despite Q3 contraction

Much-discussed tech bubble fears should be abating as Q3 growth financing activity slowed relative to the first half of the year and the same period last year.  CB Insights has relevant data here (Subscribers Only).
Screen Shot 2014-10-15 at 9.10.02 AM

Despite the mild drop in Q3 total capital commitments, CEOs considering raising capital can rely on a private growth market that is still very healthy.   The chart above affirms that 2014 investments through September 30th have already exceeded all of 2013 in volume and capital.  If Q4 stays on the Q3 pace, the market will have delivered in excess of $32 Billion of growth equity to the tech economy.   The private market capital commitment will about equal to the IPO market with the inclusion of Alibaba’s $22Bn largest IPO in history.  Normalized to exclude Alibaba, the private growth market in tech will have invested a bit more than 3x the tech IPO market to grow companies in our sector.

Private investors, traditional, crossover and strategic, continue to deliver capital in round sizes competitive with the IPO market.  Halfway through October we have already seen rounds over $100M for Houzz and Docusign and rounds of $60M or more for MetricStream, TrueCaller, Solidfire, Beepi, Alteryx, Good Technology and Minerva Project.  Rumors are about that Google may be making a $500M minority corporate venture investment in Magic Leap, a company that has not actually announced a product.  Capital in the private markets remains very much available for compelling companies.

Late Stage Bubble? – Data Say Maybe Not

Unicorns and bubble fears are making headlines, but private growth investment in tech actually declined in Q3 relative to the same period last year. The market is still active and healthy. Investment volume increased 18%. However capital committed dropped a bit as average round size contracted from $67M to $50M. Our numbers are growth deals – those over $15M – so it is not intended to capture angel, seed, typical Series A, etc. We track the volume of growth investing in North America and Europe.

Screen Shot 2014-10-07 at 6.06.38 PM

(more…)